Cargando…
Periorbital myxedema treated with intralesional hyaluronidase
PURPOSE: Periorbital myxedema is one the most challenging symptoms for patients with Graves' eye disease (GED). The treatment of this condition is complex and often unsatisfactory. This case demonstrates the use of intralesional hyaluronidase to treat cosmetically concerning periorbital myxedem...
Autores principales: | Lindgren, Aleksandra L., Sidhu, Sharleen, Welsh, Kathleen M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7262547/ https://www.ncbi.nlm.nih.gov/pubmed/32490285 http://dx.doi.org/10.1016/j.ajoc.2020.100751 |
Ejemplares similares
-
Pretibial myxedema successfully treated with intralesional hyaluronidase
por: Hoesly, Paul M., et al.
Publicado: (2018) -
Pretibial myxedema treated with intralesional hyaluronidase and triamcinolone
por: Kudlak, Natalie, et al.
Publicado: (2020) -
Pre-tibial myxedema: treatment with intralesional corticosteroid
por: Ramos, Luana Oliveira, et al.
Publicado: (2015) -
Successful Treatment of Scalp Myxedema with Injected Hyaluronidase: A Case Report
por: Menzinger, Sébastien, et al.
Publicado: (2020) -
Intralesional and topical glucocorticoids for pretibial myxedema: A case report and review of literature
por: Zhang, Fan, et al.
Publicado: (2018)